ES408226A1 - Procedimiento para preparar acidos quinazolin-4-il?indol-3-ilaceticos. - Google Patents

Procedimiento para preparar acidos quinazolin-4-il?indol-3-ilaceticos.

Info

Publication number
ES408226A1
ES408226A1 ES408226A ES408226A ES408226A1 ES 408226 A1 ES408226 A1 ES 408226A1 ES 408226 A ES408226 A ES 408226A ES 408226 A ES408226 A ES 408226A ES 408226 A1 ES408226 A1 ES 408226A1
Authority
ES
Spain
Prior art keywords
indol
quinazolinyl
amides
esters
ylacetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES408226A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES408226A1 publication Critical patent/ES408226A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES408226A 1971-11-03 1972-11-03 Procedimiento para preparar acidos quinazolin-4-il?indol-3-ilaceticos. Expired ES408226A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (1)

Publication Number Publication Date
ES408226A1 true ES408226A1 (es) 1976-02-01

Family

ID=27257588

Family Applications (2)

Application Number Title Priority Date Filing Date
ES408226A Expired ES408226A1 (es) 1971-11-03 1972-11-03 Procedimiento para preparar acidos quinazolin-4-il?indol-3-ilaceticos.
ES437331A Expired ES437311A1 (es) 1971-11-03 1975-04-30 Procedimiento para preparar acidoss quinazolin-4-il-indol-3-ilaceticos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES437331A Expired ES437311A1 (es) 1971-11-03 1975-04-30 Procedimiento para preparar acidoss quinazolin-4-il-indol-3-ilaceticos.

Country Status (17)

Country Link
US (1) US3884919A (es)
JP (1) JPS4856667A (es)
AR (3) AR198064A1 (es)
BE (1) BE790679A (es)
CA (1) CA983932A (es)
CH (1) CH577499A5 (es)
DD (1) DD105611A5 (es)
DE (1) DE2253927A1 (es)
EG (1) EG11358A (es)
ES (2) ES408226A1 (es)
FR (1) FR2158464B1 (es)
GB (1) GB1356834A (es)
HU (1) HU169711B (es)
IE (1) IE37998B1 (es)
IL (1) IL40521A (es)
NL (1) NL7214807A (es)
SE (1) SE384856B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
PL315941A1 (en) * 1994-02-23 1996-12-09 Pfizer 4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
PL343007A1 (en) * 1998-02-25 2001-07-30 Genetics Inst Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301010D0 (sv) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
ES2257616T3 (es) 2003-04-25 2006-08-01 Actimis Pharmaceuticals, Inc. Derivados del acido pirimidinilacetico utiles para el tratamiento de enfermedades mediadas por crth2.
DE602004008762T2 (de) * 2003-04-30 2008-06-12 The Institutes for Pharmaceutical Discovery, LLC, Branford Substituierte heteroarylverbindungen als inhibitoren von proteintyrosinphosphatasen
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
WO2005073234A2 (en) 2004-01-31 2005-08-11 Actimis Pharmaceuticals, Inc. Imidazo[1,2-c]pyrimidinylacetic acid derivatives
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
ATE517085T1 (de) 2004-11-23 2011-08-15 Astrazeneca Ab Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
WO2007039736A1 (en) 2005-10-06 2007-04-12 Astrazeneca Ab Novel compounds
JP2009538289A (ja) 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
WO2008012511A1 (en) 2006-07-22 2008-01-31 Oxagen Limited Compounds having crth2 antagonist activity
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
ES2383249T3 (es) 2007-09-25 2012-06-19 Actimis Pharmaceuticals, Inc. Alquiltiopirimidinas como antagonistas de CRTH2
CL2008002827A1 (es) 2007-09-25 2009-11-27 Actimis Pharmaceuticals Inc Compuestos derivados de 2-s-bencil pirimidina, antagonistas del receptor crth2; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades alergicas mediadas por eosinofilos y basofilos, tales como asma, rinitis alergica, dermatitis atopica, conjuntivitis alergica, sinusitis y psoriasis, entre otras
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
RS53142B (sr) 2008-01-18 2014-06-30 Atopix Therapeutics Limited Jedinjenja koja imaju antagonističku aktivnost na crth2
US8168673B2 (en) 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
US20100022613A1 (en) 2008-01-22 2010-01-28 Oxagen Limited Compounds Having CRTH2 Antagonist Activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
AU2019362753A1 (en) * 2018-10-05 2021-05-20 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (es) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
GB1356834A (en) 1974-06-19
IE37998B1 (en) 1977-12-07
JPS4856667A (es) 1973-08-09
DE2253927A1 (de) 1973-05-10
ES437311A1 (es) 1977-04-01
US3884919A (en) 1975-05-20
FR2158464B1 (es) 1976-07-02
CH577499A5 (es) 1976-07-15
BE790679A (fr) 1973-04-27
HU169711B (es) 1977-02-28
SE384856B (sv) 1976-05-24
CA983932A (en) 1976-02-17
EG11358A (en) 1977-02-28
IE37998L (en) 1973-05-03
FR2158464A1 (es) 1973-06-15
DD105611A5 (es) 1974-05-05
IL40521A0 (en) 1972-12-29
IL40521A (en) 1975-06-25
AR198064A1 (es) 1974-05-31
AR203627A1 (es) 1975-09-30
AR203626A1 (es) 1975-09-30
NL7214807A (es) 1973-05-07

Similar Documents

Publication Publication Date Title
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO145883C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
ES443616A1 (es) Procedimiento para la fabricacion de nuevos derivados 1,3- disustituidos del propanol-(2) y sus esteres de acido nico- tinico.
ES416877A1 (es) Procedimiento para la preparacion del nuevo compuesto acido(1-(para-clorobenzoil) - 5 - metoxi - 2 - metil - 3 - indol)acetoxi-acetico.
NL7610480A (nl) Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
IL35875A0 (en) New pharmaceutical compositions for the treatment of microbial infections containing a glutamic acid derivative
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
ES440327A1 (es) Procedimiento para la obtencion de cinnolina.
GB1126153A (en) Novel polygalacturonic acid derivative
ES435604A1 (es) Procedimiento para la preparacion de derivados de indolila- cetilaminoacidos.
GB1421589A (en) Salicylanilide derivatives
AU446727B2 (en) New derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them
SE405725B (sv) Nytt forfarande for framstellning av karboxylsyraamider
CA987314A (en) Derivatives of 9-oxo-13-trans-prostenoic acid esters
CA989309A (en) Pharmaceutical composition for the treatment of acne containing fatty acid amides
CA904340A (en) Esters of substituted anthranilic acid
GB1228080A (es)
GB1235348A (en) Pyridine carboxylic acid amides
IL38864A (en) Pharmaceutical compositions containing a pharmaceutically active penicillin and a penicilloic acid derivative
GB1327536A (en) Xanthen-2-yl-propionic acids
AU464275B2 (en) Pharmaceutical compositions comprising esters of 9-fluoro-16-methylene-prednisolone
CA981579A (en) Pharmaceutical composition comprising a derivative of 2-p-chlorophenoxy-2-methylpropionic acid and vitamin e
CA943130A (en) Process for the preparation of 4-chloro-n-furyl-5-sulfamoyl anthranilic acid
IL39984A (en) Naphthyl-substituted tetrahydrofurfuryl propionic acids,their 2-(n,n-diethylamino)ethyl esters and salt derivatives,processes for the preparation of such compounds and pharmaceutical preparations containing the ester and salt derivatives